Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
Now that weve shown that hormone-based therapies can be so effective, I think its changed the worlds perspective that its not a losing battle to treat obesity. Daniel Drucker, professor of medicine at the University of Toronto, who codiscovered GLP-1 in the 1980s, says more drugs are needed because theres no telling how long the current shortage of Wegovy and Zepbound will last
In the SURMOUNT-4 trial, participants who stopped tirzepatide after 36 weeks regained an average of around 14% of their body weight within the following year, although at 88 weeks the group that stopped had still maintained around 10% of their original weight loss overall
Li: GLP-1s do not affect everyone the same way
Food and Drug Administration (FDA) to discuss its clinical development program and manufacturing scale-up plans for its lead investigational drug MTX-001, for the treatment of venous leg ulcers
